This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07497/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07497/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB07497/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07497/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07497/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07497
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB07497 n14:DB07497
dcterms:title
5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL
adms:identifier
n4:99443968 n7:BTI n8:11840927 n9:10015432 n10:DB07497
n5:IUPAC-Name
n6:271B4A23-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4A29-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4A28-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4A25-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4A26-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4A27-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4A21-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4A22-363D-11E5-9242-09173F13E4C5 n6:271B4A1F-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4A20-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4A2F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4A30-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4A2A-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4A2B-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4A2D-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4A2C-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4A2E-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4A35-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4A37-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4A38-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4A34-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4A33-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4A36-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4A24-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4A31-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4A32-363D-11E5-9242-09173F13E4C5